Thanks to the Nova Scotia Antidote Program—launched as a pilot project in the Central Zone in 2005 and rolled out province-wide in 2009—people who ingest toxic doses of medications and other potentially dangerous substances can access an antidote no matter where in the province they live.
NSHA researchers are key players in worldwide efforts to introduce powerful new treatments for degenerative retinal diseases that, until 2007, were simply unstoppable.
Through research, teaching and clinical application, Dr. Robar, who serves as the Chief of Medical Physics at Nova Scotia Health Authority, has helped develop innovative techniques that have contributed to better patient care not only in Nova Scotia, but across the world.
The great limitation in diagnosing and treating disorders of the middle and inner ear has always been the inability to obtain high-resolution images of the delicate structures inside this bone-encased area.
